A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia
Clinical trial NCT05079919 · COMPLETED
Trial details
- NCT number
- NCT05079919
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-25
- Primary completion
- 2024-10-22
- Enrollment
- 617
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.